Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection.

Terrasson J, Allart S, Martin H, Lulé J, Haddada H, Caput D, Davrinche C.

Cancer Res. 2005 Apr 1;65(7):2787-94.

2.

Developmental roles of p73 in Cajal-Retzius cells and cortical patterning.

Meyer G, Cabrera Socorro A, Perez Garcia CG, Martinez Millan L, Walker N, Caput D.

J Neurosci. 2004 Nov 3;24(44):9878-87.

3.

Interleukin-13 alters mucociliary differentiation of human nasal epithelial cells.

Skowron M, Perret E, Marano F, Caput D, Tournier F.

Chest. 2003 Mar;123(3 Suppl):373S-4S. Review. No abstract available.

PMID:
12628987
4.

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia.

Remaury A, Vita N, Gendreau S, Jung M, Arnone M, Poncelet M, Culouscou JM, Le Fur G, Soubrié P, Caput D, Shire D, Kopf M, Ferrara P.

Brain Res. 2002 Oct 25;953(1-2):63-72.

PMID:
12384239
5.

Expression of p73 and Reelin in the developing human cortex.

Meyer G, Perez-Garcia CG, Abraham H, Caput D.

J Neurosci. 2002 Jun 15;22(12):4973-86.

6.

Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha.

Allart S, Martin H, Detraves C, Terrasson J, Caput D, Davrinche C.

J Biol Chem. 2002 Aug 9;277(32):29063-8. Epub 2002 May 28.

7.

DeltaN-p73alpha accumulates in human neuroblastic tumors.

Douc-Rasy S, Barrois M, Echeynne M, Kaghad M, Blanc E, Raguenez G, Goldschneider D, Terrier-Lacombe MJ, Hartmann O, Moll U, Caput D, Bénard J.

Am J Pathol. 2002 Feb;160(2):631-9.

8.

On the shoulders of giants: p63, p73 and the rise of p53.

Yang A, Kaghad M, Caput D, McKeon F.

Trends Genet. 2002 Feb;18(2):90-5. Review.

PMID:
11818141
9.

A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit.

Sgard F, Charpantier E, Bertrand S, Walker N, Caput D, Graham D, Bertrand D, Besnard F.

Mol Pharmacol. 2002 Jan;61(1):150-9.

10.

IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells.

Laoukili J, Perret E, Willems T, Minty A, Parthoens E, Houcine O, Coste A, Jorissen M, Marano F, Caput D, Tournier F.

J Clin Invest. 2001 Dec;108(12):1817-24.

11.

Functional characterization of neurotensin receptors in human cutaneous T cell lymphoma malignant lymphocytes.

Ramez M, Bagot M, Nikolova M, Boumsell L, Vita N, Chalon P, Caput D, Ferrara P, Bensussan A.

J Invest Dermatol. 2001 Sep;117(3):687-93.

12.

P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?

Faridoni-Laurens L, Bosq J, Janot F, Vayssade M, Le Bihan ML, Kaghad M, Caput D, Bénard J, Ahomadegbe JC.

Oncogene. 2001 Aug 30;20(38):5302-12.

13.

Genomic and allelic expression status of the p73 gene in human neuroblastoma.

Barrois M, Eychenne MK, Terrier-Lacombe MJ, Duarte N, Dubourg C, Douc-Rasy S, Chompret A, Khagad M, Hartmann O, Caput D, Bénard J.

Med Pediatr Oncol. 2001 Jan;36(1):45-7.

PMID:
11464903
14.

Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.

Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D, Nakagawara A.

Med Pediatr Oncol. 2001 Jan;36(1):42-4.

PMID:
11464902
15.

Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.

Ahomadegbe JC, Tourpin S, Kaghad M, Zelek L, Vayssade M, Mathieu MC, Rochard F, Spielmann M, Tursz T, Caput D, Riou G, Bénard J.

Oncogene. 2000 Nov 9;19(47):5413-8.

17.

Mutation analysis of P73 and TP53 in Merkel cell carcinoma.

Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML, Van Belle S, Cocquyt V, Bridge J, Sciot R, De Wolf-Peeters C, De Paepe A, Caput D, Speleman F.

Br J Cancer. 2000 Feb;82(4):823-6.

18.

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.

Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D.

Nature. 2000 Mar 2;404(6773):99-103.

PMID:
10716451
19.
20.

Identification and transcription control of fission yeast genes repressed by an ammonium starvation growth arrest.

Bonnet C, Perret E, Dumont X, Picard A, Caput D, Lenaers G.

Yeast. 2000 Jan 15;16(1):23-33.

21.
22.

p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.

Davison TS, Vagner C, Kaghad M, Ayed A, Caput D, Arrowsmith CH.

J Biol Chem. 1999 Jun 25;274(26):18709-14.

23.

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F.

Nature. 1999 Apr 22;398(6729):714-8.

PMID:
10227294
24.

Differentially expressed genes in C6.9 glioma cells during vitamin D-induced cell death program.

Baudet C, Perret E, Delpech B, Kaghad M, Brachet P, Wion D, Caput D.

Cell Death Differ. 1998 Jan;5(1):116-25.

25.

Construction of two ordered cDNA libraries enriched in genes encoding plasmalemma and tonoplast proteins from a high-efficiency expression library.

Galaud JP, Carrière M, Pauly N, Canut H, Chalon P, Caput D, Pont-Lezica RF.

Plant J. 1999 Jan;17(1):111-8.

26.

p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.

Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D, Nakagawara A.

Oncogene. 1999 Jan 28;18(4):1061-6.

27.

Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA.

Gueydan C, Droogmans L, Chalon P, Huez G, Caput D, Kruys V.

J Biol Chem. 1999 Jan 22;274(4):2322-6.

28.

Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells.

Vita N, Oury-Donat F, Chalon P, Guillemot M, Kaghad M, Bachy A, Thurneyssen O, Garcia S, Poinot-Chazel C, Casellas P, Keane P, Le Fur G, Maffrand JP, Soubrie P, Caput D, Ferrara P.

Eur J Pharmacol. 1998 Nov 6;360(2-3):265-72.

PMID:
9851594
29.

Viral oncoproteins discriminate between p53 and the p53 homolog p73.

Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D, Kaelin WG Jr.

Mol Cell Biol. 1998 Nov;18(11):6316-24.

30.

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F.

Mol Cell. 1998 Sep;2(3):305-16.

31.

Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step.

Labit-Le Bouteiller C, Jamme MF, David M, Silve S, Lanau C, Dhers C, Picard C, Rahier A, Taton M, Loison G, Caput D, Ferrara P, Lupker J.

Eur J Biochem. 1998 Sep 1;256(2):342-9.

32.

The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor.

Mazella J, Zsürger N, Navarro V, Chabry J, Kaghad M, Caput D, Ferrara P, Vita N, Gully D, Maffrand JP, Vincent JP.

J Biol Chem. 1998 Oct 9;273(41):26273-6.

33.

IL-13 increases the cPLA2 gene and protein expression and the mobilization of arachidonic acid during an inflammatory process in mouse peritoneal macrophages.

Rey A, M'Rini C, Sozzani P, Lamboeuf Y, Beraud M, Caput D, Ferrara P, Pipy B.

Biochim Biophys Acta. 1998 Aug 28;1393(2-3):244-52.

PMID:
9748607
34.

Tissue distribution and cellular localization of the levocabastine-sensitive neurotensin receptor mRNA in adult rat brain.

Walker N, Lepee-Lorgeoux I, Fournier J, Betancur C, Rostene W, Ferrara P, Caput D.

Brain Res Mol Brain Res. 1998 Jun 15;57(2):193-200.

PMID:
9675417
35.

The cell cycle gene SKP1 is regulated by light in postnatal rat brain.

Uro-Coste E, Perret E, Fonta C, Mathieu M, Delisle MB, Caput D, Imbert M.

Brain Res Mol Brain Res. 1998 May;56(1-2):192-9.

PMID:
9602124
36.

Inhibition of lysophosphatidic acid-induced neurite retraction and cell rounding by SR 57746A.

Magazin M, Schiltz P, Zachayus JL, Cavrois E, Caput D, Ferrara P.

Brain Res Mol Brain Res. 1998 Jan;53(1-2):301-6.

PMID:
9473704
37.

[P73: a kin to the p52 tumor suppressor gene].

Caput D.

Bull Cancer. 1997 Nov;84(11):1081-2. French.

38.

IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production.

Sozzani P, Hasan L, Séguélas MH, Caput D, Ferrara P, Pipy B, Cambon C.

Biochem Biophys Res Commun. 1998 Mar 27;244(3):665-70.

PMID:
9535722
39.

Improved differential screening approach to analyse transcriptional variations in organized cDNA libraries.

Perret E, Ferrán EA, Marinx O, Liauzun P, Dumont X, Fournier J, Kaghad M, Ferrara P, Caput D.

Gene. 1998 Feb 27;208(2):103-15.

PMID:
9524236
40.

Early expression of a beta1-adrenergic receptor and catecholamines in Xenopus oocytes and embryos.

Devic E, Paquereau L, Steinberg R, Caput D, Audigier Y.

FEBS Lett. 1997 Nov 10;417(2):184-90.

41.

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D.

Cell. 1997 Aug 22;90(4):809-19.

42.

The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes.

Minty A, Asselin S, Bensussan A, Shire D, Vita N, Vyakarnam A, Wijdenes J, Ferrara P, Caput D.

Eur Cytokine Netw. 1997 Jun;8(2):203-13.

44.
45.

Expression of SKP1 mRNA and protein in rat brain during postnatal development.

Uro-Coste E, Fonta C, Hatey F, Perret E, Delisle MB, Caput D, Imbert M.

Neuroreport. 1997 May 6;8(7):1675-8.

PMID:
9189913
46.

Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation.

Billard C, Caput D, Vita N, Ferrara P, Orrico M, Gaulard P, Boumsell L, Bensussan A, Farcet JP.

Eur Cytokine Netw. 1997 Mar;8(1):19-27.

PMID:
9110144
47.

Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex.

Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N, Ferrara P.

FEBS Lett. 1997 Jan 20;401(2-3):163-6.

48.

Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13.

Kolios G, Robertson DA, Jordan NJ, Minty A, Caput D, Ferrara P, Westwick J.

Br J Pharmacol. 1996 Sep;119(2):351-9.

49.

Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain.

Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, Ferrara P.

J Biol Chem. 1996 Jul 12;271(28):16921-6.

50.

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.

Shire D, Calandra B, Rinaldi-Carmona M, Oustric D, Pessègue B, Bonnin-Cabanne O, Le Fur G, Caput D, Ferrara P.

Biochim Biophys Acta. 1996 Jun 7;1307(2):132-6.

PMID:
8679694

Supplemental Content

Support Center